tradingkey.logo
tradingkey.logo
Search

Top 10 US Stock Losers (11.4)

LongportNov 4, 2026 10:01 PM
facebooktwitterlinkedin
View all comments(0)

NASDAQ Composite Index has rose 1.44%, with a year-to-date rose 10.7%; S&P 500 has rose 1.58%, with a year-to-date rose 12.3%; Dow Jones Industrial Average has rose 3.03%, with a year-to-date rose 11%.

Nurix Therapeutics(NRIX) fell 38.23%, with a trading turnover 305.3 Million USD, and a year-to-date fell 15.9%.

Amdocs(DOX) fell 30.07%, with a trading turnover 415.3 Million USD, and a year-to-date fell 44.1%.

Everus Construction(ECG) fell 29.29%, with a trading turnover 289.1 Million USD, and a year-to-date fell 6.8%.

StockChangeTurnoverMarket CapYTD Change
Nurix Therapeutics(NRIX)-38.23%305.3 Million USD1.7 Billion USD-15.9%
Amdocs(DOX)-30.07%415.3 Million USD4.6 Billion USD-44.1%
Everus Construction(ECG)-29.29%289.1 Million USD4.1 Billion USD-6.8%
Syndax Pharma(SNDX)-26.87%164.8 Million USD933.2 Million USD-50.3%
Trump Media & Tech(DJT)-24.54%106.3 Million USD1.2 Billion USD-66.1%
Fidelity National Information(FIS)-23.67%1.1 Billion USD15.3 Billion USD-53.8%
Hut 8 Mining(HUT)-23.23%708.3 Million USD6.0 Billion USD+6.5%
Kura Oncology(KURA)-22.98%65.2 Million USD677.0 Million USD-26.8%
Target Hospitality(TH)-22.08%85.2 Million USD1.1 Billion USD+40.9%
Sterling Infrastructure(STRL)-21.46%937.8 Million USD8.7 Billion USD-7.4%
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.